Initial Nintedanib Dose and Treatment Continuation in Patients With Connective Tissue Disease‐Associated Interstitial Lung Disease: A Retrospective Single‐Center Observational Study in Japan | Synapse
June 29, 2026International Journal of Rheumatic Diseases0 citations
Initial Nintedanib Dose and Treatment Continuation in Patients With Connective Tissue Disease‐Associated Interstitial Lung Disease: A Retrospective Single‐Center Observational Study in Japan
To investigate the relationship between initial nintedanib dosage and treatment continuation in patients with connective tissue disease-associated interstitial lung disease.
Retrospective single-center observational study in Japan
Analysis of patient treatment records
Evaluation of initial nintedanib doses and their impact on continuation rates.
Higher initial doses of nintedanib were associated with improved treatment continuation rates over time.
Specific statistics on continuation rates or patient outcomes were not detailed.
Abstract
The data that support the findings of this study are available from the corresponding author upon reasonable request.